Advanced search
Publication Cover
Renal Failure Volume 35, 2013 - Issue 1
Submit an article Journal homepage
526
Views
1
CrossRef citations to date
0
Altmetric
Article

The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with End-Stage Renal Disease and Microscopic Hematuria

Brandon TrojanDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
,
Andrew TangDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
,
Jason ChandrapalDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
,
Stephanie FilleurDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA;Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
&
Thomas NeliusDepartment of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, USACorrespondence[email protected]
Pages 72-76 | Received 26 Jul 2012, Accepted 09 Oct 2012, Published online: 14 Nov 2012

REFERENCES

  • Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M. EAU guidelines on renal transplantation. Eur Urol. 2005;47:156–66.
  • USRDS. Annual Data Report. United States Renal Data System Web site. 2010. Available at: www.usrds.org/adr.htm. Accessed June 4, 2012.
  • Sackett DD, Singh P, Lallas CD. Urological involvement in renal transplantation. Int J urol. 2011;18:185–93.
  • Power RE. Hickey DP and little DM: urological evaluation prior to renal transplantation. Transplant Proc. 2004;36:2962–7.
  • Barry JM. Current status of renal transplantation. Patient evaluations and outcomes. Urol Clin North Am. 2001;28:677–86.
  • Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–13.
  • AUA. Clinical guidelines. 2012. Available at: http://www.auanet.org/content/media/asymptomatic_microhematuria_guideline.pdf. Accessed June 4, 2012.
  • Todenhofer T, Hennenlotter J, Witstruk M, . Influence of renal excretory function on the performance of urine based markers to detect bladder cancer. J Urol. 2012;187:68–73.
  • Shariat SF, Marberger MJ, Lotan Y, . Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. J Urol. 2006;176:919–26, discussion 926.
  • Budman LI, Kassouf W, Steinberg JR. Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J. 2008;2:212–21.
  • Atsu N, Ekici S, Oge OO, Ergen A, Hascelik G, Ozen H. False-positive results of the NMP22 test due to hematuria. J Urol. 2002;167:555–8.
  • Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM. The accuracy of urinary cytology in daily practice. Cancer. 1999; 87:118–28.
  • Ponsky LE, Sharma S, Pandrangi L, . Screening and monitoring for bladder cancer: refining the use of NMP22. J Urol. 2001;166:75–8.
  • Raitanen MP, Kaasinen E, Lukkarinen O, . Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer. Urology. 2001;57:680–4.
  • Todenhofer T, Hennenlotter J, Tews V, . Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma. Urol Oncol. 2011; [Epub ahead of print].
  • Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101:519–20.
  • Chiarelli F, Verrotti A, Mohn A, Morgese G. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications. Ann Med. 1997;29:439–45.
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70.
  • Sharma S, Zippe CD, Pandrangi L, Nelson D, Agarwal A. Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat. J Urol. 1999;162:53–7.
  • Miyanaga N, Akaza H, Ishikawa S, . Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol. 1997;31:163–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.